A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This will be a Phase II, multi-centre study consisting of 2 parts. Part 1: Clinical
Pharmacology Study (drug-drug interaction between AK106-001616 and methotrexate) Part 2:
Proof of Concept Study